Exchange: NASDAQ·Updated 04:26 PM EDT

About SLRX

About

Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company was founded by Frederick E. Pierce, Barbara Hibner, Peter Marschel, Michael Lipp, and Jodi Cooper in 2020 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
11

Frequently Asked Questions

Advertisement|Remove ads.